AKT1 and breast carcinoma: Some studies have suggested that niacin treatment activates AKT protein, a cell survival factor in human epithelial carcinoma cell lines, and inhibits metastatic activity by enhancing the NAD+/NADH ratio in cultured MDA-MB-435 and MDA-MB-231 human breast carcinoma cells [5, 6].